Nordic MPD Study Group - Guidelines eosinophilia

Guidelines MPN Read more »

Guidelines eosinophilia

The Nordic study group on myeloproliferative neoplasms (NMPN) decided in 2007 to write a proposal for guidelines on hypereosinophilic states, based on already existing national and international recommendations. The aim has been to write a document that can be used in all Nordic countries for clinical as well as educational purposes. Therefore, numerous illustrations are given with references, including on-line linking from the document to relevant websites, which may all be used, some with permissions as stated at the end of the document in a separate section.

Hypereosinophilia in haematology is one of the very rare conditions, and solid evidence based on large protocols or randomized trials are lacking. This proposal for guidelines tend to give current best evidence and interpretation in making decisions, based upon the development reported in diagnostic work-up and therapy.

The guidelines are written for health professionals with a speciality or interest in haematology. They incorporate the new diagnostic criteria established by the World Health Organization 2008. We plan further updates on a bi-annual basis, and it is therefore recommended that colleagues use the on-line version, rather than to print and copy paper versions of the document, and to send comments for improvements.

NORDIC_GUIDELINE_EOSINOPHILIA_04-2009_pub.pdf

Writing committee:

• Ole Weis Bjerrum, Copenhagen
• Tarja-Terttu Pelliniemi, Turku
• Hans Wadenvik, Gothenburg

for the Nordic MPN Study Group, April 2009
©Nordic MPN Group 2010

Article by Bjorkholm et al on risk factors for transformation in MPN:s now published on-line in JCO.

QoL article by Scherber et al published on-line in Blood.

Article on outcome of allo-SCT in PMF by Abelsson et al on-line in Bone Marrow Transplant.

Members can find complete articles on the members page.